By Counterforce Health Team in Keppra (levetiracetam) —

How to Get Keppra (Levetiracetam) Covered by Aetna (CVS Health) in Georgia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Keppra (Levetiracetam) Covered by Aetna (CVS Health) in Georgia

Quick Answer: Aetna (CVS Health) requires step therapy for brand Keppra—patients must try generic levetiracetam first. If the generic fails or causes intolerance, your doctor can request prior authorization for brand Keppra through Aetna's provider portal or CVS Caremark. Standard approvals take 5-15 business days; expedited reviews for urgent seizure control take 24-72 hours. If denied, you have 180 days to appeal internally, then 60 days for external review through Georgia's Department of Insurance.

First step today: Ask your doctor to prescribe generic levetiracetam (covered without prior auth) or submit a brand medical necessity request with documentation of generic failure.

Table of Contents

  1. Coverage at a Glance
  2. Step-by-Step: Fastest Path to Approval
  3. When Generic Levetiracetam Makes Sense
  4. Typical Alternatives on Aetna's Formulary
  5. Exception Strategy: Getting Brand Keppra Approved
  6. Appeals Playbook for Aetna in Georgia
  7. Common Denial Reasons & How to Fix Them
  8. Costs & Savings Options
  9. FAQ
  10. When to Escalate to Georgia Regulators

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Not needed for generic levetiracetam; required for brand Keppra Aetna formulary 2026 Standard Plan Formulary
Step Therapy Must try generic levetiracetam before brand Keppra Generic Step Therapy Drug List Aetna 2026 GST Policy
Formulary Tier Generic: Tier 1 (preferred); Brand: Non-preferred Plan documents Aetna Drug Guide 2026
Appeal Deadline 180 days for internal; 60 days for external review Denial letter Georgia DOI External Review
Expedited Review 24-72 hours if delay risks health Provider request Aetna PA Guidelines

Step-by-Step: Fastest Path to Approval

Option 1: Generic First (No Prior Auth Needed)

  1. Doctor prescribes generic levetiracetam - Covered as Tier 1 preferred drug
  2. Fill at any in-network pharmacy - Standard copay applies
  3. Monitor effectiveness - Track seizure control and side effects
  4. Document any failures - Save records for future brand request if needed

Option 2: Brand Keppra (Requires Prior Authorization)

  1. Gather failure documentation - Records showing generic levetiracetam didn't work or caused intolerance
  2. Doctor submits PA request - Via Aetna provider portal or CVS Caremark fax
  3. Include medical necessity letter - Explaining why brand is specifically needed
  4. Wait for decision - 5-15 business days standard; 24-72 hours if expedited
  5. If approved, fill prescription - Higher copay for non-preferred brand
  6. If denied, file appeal - Within 180 days with additional evidence

When Generic Levetiracetam Makes Sense

Generic levetiracetam is Aetna's preferred option and works for most patients with epilepsy. The FDA considers generic levetiracetam bioequivalent to brand Keppra, meaning it delivers the same amount of active medication to your bloodstream.

Good candidates for generic include:

  • New epilepsy diagnoses starting treatment
  • Patients stable on brand Keppra who can switch
  • Those seeking lower out-of-pocket costs
  • Patients without previous generic intolerance

When generic might not work:

  • Allergy to specific inactive ingredients in generics
  • Previous documented failure on generic formulation
  • Absorption issues requiring consistent brand formulation
  • Severe seizure disorder requiring precise medication levels
Note: Under Georgia law, pharmacists can substitute generics unless your doctor writes "brand medically necessary" on the prescription.

Typical Alternatives on Aetna's Formulary

If levetiracetam (generic or brand) isn't suitable, Aetna covers several other anti-seizure medications without prior authorization:

Preferred Options (Tier 1)

  • Lamotrigine - Broad-spectrum; good for partial and generalized seizures
  • Gabapentin - Partial seizures; fewer drug interactions
  • Topiramate - Partial and generalized seizures; weight loss potential
  • Phenytoin - Partial and tonic-clonic seizures; requires blood level monitoring
  • Valproic acid - Broad-spectrum; not recommended for women of childbearing age

Considerations by Seizure Type

Seizure Type First-Line Options Monitoring Needed
Partial-onset Lamotrigine, gabapentin, topiramate Rash monitoring (lamotrigine)
Generalized tonic-clonic Lamotrigine, valproic acid Blood levels (valproate)
Myoclonic Valproic acid, lamotrigine Liver function (valproate)
Absence Lamotrigine, valproic acid Weight changes (topiramate)
Important: Never stop seizure medications abruptly. Work with your neurologist to create a switching plan that gradually tapers one medication while starting another.

Exception Strategy: Getting Brand Keppra Approved

When generic levetiracetam isn't suitable, you'll need to prove medical necessity for brand Keppra. Here's what strengthens your case:

Required Documentation

  • Previous generic trial records - Dates, doses, duration, and specific problems
  • Seizure logs - Frequency and severity before/during generic trial
  • Side effect documentation - Specific adverse reactions to generic formulation
  • Neurologist letter - Clinical justification for brand-name product
  • Pharmacy records - Proof of generic dispensing and patient compliance

Medical Necessity Letter Checklist

Your doctor's letter should include:

  • Patient's specific epilepsy diagnosis and ICD-10 code
  • Complete seizure history and current control status
  • Detailed account of generic levetiracetam trial (dose, duration, outcome)
  • Specific reasons generic failed (breakthrough seizures, intolerance, etc.)
  • Clinical rationale why brand Keppra is medically necessary
  • Reference to FDA labeling or epilepsy treatment guidelines
  • Statement that no other suitable alternatives exist
Clinician Corner: The most successful appeals include objective evidence like EEG changes, emergency room visits for breakthrough seizures, or documented side effects that resolved when switching back to brand medication.

Appeals Playbook for Aetna in Georgia

Internal Appeal Process

Timeline: File within 180 days of denial; decision in 30-45 business days (72 hours if expedited)

How to file:

  • Online: Aetna member portal (login required)
  • Phone: Number on your member ID card
  • Mail: Address provided in denial letter
  • Provider: Availity portal for healthcare professionals

Required documents:

  • Original denial letter
  • Completed appeal form
  • Additional medical evidence
  • Doctor's letter supporting medical necessity
  • Pharmacy records showing compliance

External Review Through Georgia DOI

If your internal appeal is denied, Georgia law gives you a second chance through independent external review.

Timeline: File within 60 days of final internal denial; decision in 30 business days (72 hours if expedited)

How to file: Submit application to Georgia Department of Insurance Consumer Services

What happens: Independent physicians review your case and make a binding decision. If they rule in your favor, Aetna must cover the medication.

Cost: Free to consumers

Georgia Advantage: You can request expedited external review concurrent with internal appeals if your condition is urgent—you don't have to wait for internal completion if delay poses serious health risks.

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Documents Needed
Step therapy not met Prove generic trial failure Pharmacy records, seizure logs, doctor notes
Not medically necessary Show clinical need for brand EEG results, treatment history, specialist letter
Insufficient documentation Submit complete medical records Chart notes, lab results, prior authorizations
Alternative available Demonstrate why alternatives won't work Allergy records, previous failures, contraindications
Experimental/investigational Cite FDA approval and guidelines FDA labeling, treatment guidelines, peer-reviewed studies

Scripts for Common Situations

Requesting peer-to-peer review (for providers): "I'm requesting a peer-to-peer review for my patient's Keppra prior authorization denial. The patient has documented intolerance to generic levetiracetam with breakthrough seizures. I can provide additional clinical details to your medical director."

Following up on pending appeals: "I'm calling to check the status of my appeal for Keppra coverage. My reference number is [X]. Can you tell me what additional information is needed and the expected decision date?"

Costs & Savings Options

If Keppra Gets Approved

  • Aetna copay: Varies by plan (typically $30-100+ for non-preferred brands)
  • Manufacturer support: UCB no longer markets brand Keppra in the US, so manufacturer programs aren't available
  • Generic savings: Levetiracetam generic can cost under $20 for 60 tablets at some pharmacies

If Coverage is Denied

  • GoodRx coupons: Can reduce generic levetiracetam costs significantly
  • Pharmacy discount programs: Many chains offer generic medication discounts
  • Patient assistance foundations: Partnership for Prescription Assistance helps find programs
  • State programs: Georgia may have additional assistance for low-income residents

At Counterforce Health, we help patients navigate exactly these kinds of coverage challenges. Our platform analyzes denial letters and creates targeted appeals that address the specific reasons insurers cite for rejecting medication requests, turning complex insurance policies into clear action plans.

FAQ

How long does Aetna prior authorization take for Keppra in Georgia? Standard reviews take 5-15 business days. Expedited reviews for urgent medical conditions are completed within 24-72 hours.

What if Keppra isn't on Aetna's formulary at all? Generic levetiracetam is on preferred formularies. If you need brand Keppra specifically, you can request a formulary exception with medical necessity documentation.

Can I appeal if I've been stable on Keppra from another state? Yes. Document your treatment history and current stability. Georgia and Aetna should honor medically necessary treatments from other states.

Does step therapy apply if I failed generic levetiracetam years ago? It depends on how recent the trial was and whether it's documented in your medical records. Aetna may require a recent trial within the past year.

What counts as "urgent" for expedited appeals? Conditions where delay could seriously jeopardize your health, ability to regain function, or cause severe pain. Uncontrolled epilepsy often qualifies.

Can I get help with the appeal process? Yes. Counterforce Health specializes in turning insurance denials into successful appeals, and Georgia offers consumer assistance through the DOI Consumer Services Division.

When to Escalate to Georgia Regulators

Contact Georgia's Department of Insurance if:

  • Aetna violates appeal deadlines
  • You suspect the denial violates Georgia insurance law
  • The external review process isn't followed properly
  • You need help understanding your rights

Georgia Department of Insurance Consumer Services

  • Phone: 1-800-656-2298
  • Website: www.oci.ga.gov
  • Complaint form: Available online for insurance disputes
From Our Advocates: We've seen cases where patients were initially denied Keppra coverage due to "insufficient documentation," but after submitting a comprehensive appeal with seizure logs, EEG results, and a detailed neurologist letter explaining why generic alternatives had failed, the coverage was approved within the expedited 72-hour timeline. The key was providing objective evidence that directly addressed each point in the denial letter.

Disclaimer: This information is for educational purposes only and is not medical or legal advice. Insurance policies and state regulations change frequently. Always verify current requirements with Aetna and consult your healthcare provider for medical decisions.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.